Search Results - "TAHARA, M."

This result is not displayed to guests.
Login for full access.

CONSISTENCY OF DIFFERENTIALLY EXPRESSED GENES IN THE SUBCHONDRAL BONE OF END-STAGE OSTEOARTHRITIC KNEES.

Authors: NAGASHIMA, R. TAHARA, M. AKAGI, R. et al.

Source: Joints. 2023, Issue 1, p1-11.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

RORγt antagonist suppresses M3 muscarinic acetylcholine receptor-induced Sjögren's syndrome-like sialadenitis.

Authors: Tahara, M. Tsuboi, H. Segawa, S. et al.

Source: Clinical & Experimental Immunology. Feb2017, Vol. 187 Issue 2, p213-224. 12p.

WIDE-RANGE TEMPERATURE DEPENDENCE OF BRILLOUIN FREQUENCY SHIFT IN PLASTIC OPTICAL FIBER.

Authors: Minakawa, K. Hayashi, N. Shinohara, Y. et al.

Source: International Conference on POF Proceedings; 2013, p72-75, 4p

This result is not displayed to guests.
Login for full access.

T-bet regulates differentiation of forkhead box protein 3⁺ regulatory T cells in programmed cell death-1-deficient mice.

Authors: Tahara, M. Kondo, Y. Yokosawa, M. et al.

Source: Clinical & Experimental Immunology. Feb2015, Vol. 179 Issue 2, p197-209. 13p.

Development of analytical method for determination of 1,4-dioxane in cleansing products.

Authors: Tahara, M. Obama, T. Ikarashi, Y.

Source: International Journal of Cosmetic Science. Dec2013, Vol. 35 Issue 6, p575-580. 6p.

Phase I/II study of oxaliplatin with oral S-1 as first-line therapy for patients with metastatic colorectal cancer.

Authors: Yamada, Y. Tahara, M. Miya, T. et al.

Source: British Journal of Cancer. 3/18/2008, Vol. 98 Issue 6, p1034-1038. 5p. 3 Charts, 2 Graphs.

This result is not displayed to guests.
Login for full access.

Pembrolizumab with or Without Lenvatinib As First-line Therapy for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC): Phase 3 LEAP-010 Study.

Authors: Licitra, L. Tahara, M. Harrington, K. et al.

Source: International Journal of Radiation Oncology, Biology, Physics. Apr2024, Vol. 118 Issue 5, pe2-e3. 2p.

Subjects: Squamous cell carcinoma, Adverse health care events, Pembrolizumab

This result is not displayed to guests.
Login for full access.

O6-2 Real-world treatment patterns of patients with locally advanced squamous cell carcinoma of the head and neck in Japan.

Authors: Nibu, K. Tahara, M. Yoshimi, N. et al.

Source: Annals of Oncology. Oct2024:Supplement 3, Vol. 35, pS1318-S1318. 1p.

O6-1 Post-hoc analysis of TRAEs observed in a phase 2 study of encorafenib + binimetinib in metastatic BRAF V600-mutated TC.

Authors: Takahashi, S. Tahara, M. Kiyota, N. et al.

Source: Annals of Oncology. Oct2024:Supplement 3, Vol. 35, pS1317-S1317. 1p.

This result is not displayed to guests.
Login for full access.

851MO Final analysis of a phase II/III trial of post-operative chemoradiotherapy comparing 3-weekly cisplatin with weekly cisplatin in high-risk patients with squamous cell carcinoma of the head and neck (JCOG1008).

Authors: Tahara, M. Kiyota, N. Fujii, H. et al.

Source: Annals of Oncology. 2024 Supplement 2, Vol. 35, pS615-S615. 1p.

Phase II trial of combination treatment with paclitaxel, carboplatin and cetuximab (PCE) as first-line treatment in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck (CSPOR-HN02).

Authors: Tahara, M Kiyota, N Yokota, T et al.

Source: Annals of Oncology. Apr2018, Vol. 29 Issue 4, p1004-1009. 6p. 3 Charts, 2 Graphs.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.